Related Experiment Video
Updated: Aug 9, 2025

Live-cell Imaging of Fungal Cells to Investigate Modes of Entry and Subcellular Localization of Antifungal Plant Defensins
Published on: December 24, 2017
Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria
Gabriela Marinho Righetto1, José Luiz de Souza Lopes2, Paulo José Martins Bispo3
1Laboratory of Molecular Epidemiology and Microbiology, Department of Physics and Interdisciplinary Science, São Carlos Institute of Physics, University of São Paulo, São Carlos 13563-120, Brazil.
Abstract:
Antimicrobial resistance poses a major threat to public health. Given the paucity of novel antimicrobials to treat resistant infections, the emergence of multidrug-resistant bacteria renewed interest in antimicrobial peptides as potential therapeutics. This study designed a new analog of the antimicrobial peptide Plantaricin 149 (Pln149-PEP20) based on previous Fmoc-peptides. The minimal inhibitory concentrations of Pln149-PEP20 were determined for 60 bacteria of different species and resistance profiles, ranging from 1 mg/L to 128 mg/L for Gram-positive bacteria and 16 to 512 mg/L for Gram-negative. Furthermore, Pln149-PEP20 demonstrated excellent bactericidal activity within one hour. To determine the propensity to develop resistance to Pln149-PEP20, a directed-evolution in vitro experiment was performed. Whole-genome sequencing of selected mutants with increased MICs and wild-type isolates revealed that most mutations were concentrated in genes associated with membrane metabolism, indicating the most likely target of Pln149-PEP20. Synchrotron radiation circular dichroism showed how this molecule disturbs the membranes, suggesting a carpet mode of interaction. Membrane depolarization and transmission electron microscopy assays supported these two hypotheses, although a secondary intracellular mechanism of action is possible. The molecule studied in this research has the potential to be used as a novel antimicrobial therapy, although further modifications and optimization remain possible.
Insights
A novel antimicrobial peptide, Pln149-PEP20, shows potent bactericidal activity against multidrug-resistant bacteria. This peptide likely targets bacterial membranes, offering a promising new therapeutic avenue for combating antimicrobial resistance.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Antimicrobial resistance (AMR) is a significant global health threat.
- Novel antimicrobial agents are urgently needed to combat multidrug-resistant (MDR) bacteria.
- Antimicrobial peptides (AMPs) are being investigated as potential therapeutics against resistant infections.
Purpose of the Study:
- To design and characterize a novel analog of the antimicrobial peptide Plantaricin 149 (Pln149-PEP20).
- To evaluate the antimicrobial activity and resistance development potential of Pln149-PEP20.
- To elucidate the mechanism of action of Pln149-PEP20 against bacteria.
Main Methods:
- Minimal inhibitory concentrations (MICs) determination for 60 bacterial strains.
- In vitro directed-evolution experiment to assess resistance development.
- Whole-genome sequencing of resistant mutants.
- Synchrotron radiation circular dichroism, membrane depolarization, and transmission electron microscopy (TEM) assays.
Main Results:
- Pln149-PEP20 exhibited potent bactericidal activity against Gram-positive and Gram-negative bacteria, with MICs ranging from 1 to 512 mg/L.
- Most mutations in resistant mutants were found in genes related to membrane metabolism.
- Pln149-PEP20 was shown to disturb bacterial membranes, suggesting a carpet-like mechanism of action.
Conclusions:
- Pln149-PEP20 demonstrates significant potential as a novel antimicrobial therapeutic.
- The peptide's primary mechanism involves disruption of bacterial membranes.
- Further optimization of Pln149-PEP20 may lead to effective treatments for resistant bacterial infections.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness
Development of Antibiotic Resistance

